VeriStrat(®) has prognostic value in advanced stage NSCLC patients treated with erlotinib and sorafenib. - Kuiper JL; Lind JS; Groen HJ; Roder J; Grigorieva J; Roder H; Dingemans AM; Smit EF; Kuiper, J L; Lind, J S W; Groen, H J M; Roder, J; et al. (British Journal of Cancer, 2012)